ResMed’s Executive Stock Transactions Highlight Compensation Practices

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.

Michael J. Rider, Global General Counsel at ResMed Inc, reported the sale of multiple restricted stock units to cover tax withholding obligations from vesting events. These transactions, executed at a price of $252.38 per share, reflect common practices in managing compensation packages tied to company performance. Investors might view these transactions as a routine part of executive compensation management.

For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.